Cbd Biomedica (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 50.00 K
- Company Age 5 Year, 7 Months
About Cbd Biomedica (India)
Cbd Biomedica (India) Private Limited (CBIPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 June 2019 (Five years and seven months 13 days old ). Its registered office is in Solan, Himachal Pradesh, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 50.00 K , as per Ministry of Corporate Affairs (MCA) records.
Jas Dhaliwal and Pavneet Kaur serve as directors at the Company.
Company Details
-
Location
Solan, Himachal Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U01100HP2019PTC007503
-
Company No.
007503
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Jun 2019
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Himachal Pradesh
Industry
Who are the key members and board of directors at Cbd Biomedica (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jas Dhaliwal
|
Director | 20-Jun-2019 | Current |
|
Pavneet Kaur
|
Director | 20-Jun-2019 | Current |
Financial Performance of Cbd Biomedica (India).
Enhance accessibility to Cbd Biomedica (India)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cbd Biomedica (India)?
Unlock access to Cbd Biomedica (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Whistler Logistics Private LimitedJas Dhaliwal is a mutual person
-
Prina Era Energy Resources Private LimitedJas Dhaliwal and Pavneet Kaur are mutual person
-
Whistler Spirits & Beverages Private Limited
Jas Dhaliwal is a mutual person
-
Whistler Spirits Private Limited
Jas Dhaliwal is a mutual person
-
Prina Energy Private Limited
Pavneet Kaur is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cbd Biomedica (India)?
Unlock and access historical data on people associated with Cbd Biomedica (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cbd Biomedica (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cbd Biomedica (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.